TABLE IV.

Serious adverse events occurring in two or more patients

Event	Patient group [n(%)]
	CLL (n=16)	iNHL (n=74)	Overall (n=90)
Any event	6 (37.5)	27 (36.5)	33 (36.7)
Pyrexia	3 (18.8)	6 (8.1)	9 (10.0)
Febrile neutropenia	1 (6.3)	4 (5.4)	5 (5.6)
Pneumonia	0	3 (4.1)	3 (3.3)
Acute renal failure	1 (6.3)	2 (2.7)	3 (3.3)
Abdominal pain	0	2 (2.7)	2 (2.2)
Hypotension	1 (6.3)	1 (1.4)	2 (2.2)
Nausea	0	2 (2.7)	2 (2.2)
Pneumocystis jiroveci pneumonia	0	2 (2.7)	2 (2.2)
Syncope	0	2 (2.7)	2 (2.2)
Tumour lysis syndrome	2 (12.5)	0	2 (2.2)
Vomiting	0	2 (2.7)	2 (2.2)

CLL = chronic lymphocytic leukemia; iNHL = indolent non-Hodgkin lymphoma.